Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of the Surgical Approach for Neoadjuvantly Treated Gastroesophageal Junction Type II Tumors: A Multinational, High-volume Center Retrospective Cohort Analysis.
Wirsik NM, Schmidt T, Nienhüser H, Donlon NE, de Jongh C, Uzun E, Fuchs HF, Brunner S, Alakus H, Hölscher AH, Grimminger P, Schneider M, Reynolds JV, van Hillegersberg R, Bruns CJ. Wirsik NM, et al. Among authors: alakus h. Ann Surg. 2023 Nov 1;278(5):683-691. doi: 10.1097/SLA.0000000000006011. Epub 2023 Jul 31. Ann Surg. 2023. PMID: 37522845
[18F]Fluorodeoxyglucose positron emission tomography/computed tomography-positive gastric adenocarcinoma in a 12-year-old girl with Peutz-Jeghers syndrome.
Schneider C, Simon T, Hero B, Uphoff US, Drebber U, Alakus H, Holinski-Feder E, Berthold F, Dietlein M, Schmidt MC. Schneider C, et al. Among authors: alakus h. J Clin Oncol. 2012 May 10;30(14):e140-3. doi: 10.1200/JCO.2011.39.7422. Epub 2012 Apr 9. J Clin Oncol. 2012. PMID: 22493416 No abstract available.
No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia.
Riemann K, Becker L, Struwe H, Nückel H, Dührsen U, Alakus H, Winde G, Neuhäuser M, Rübben H, Schmitz KJ, Wohlschlaeger J, Schmid KW, Siffert W. Riemann K, et al. Among authors: alakus h. Pharmacogenet Genomics. 2006 Nov;16(11):783-8. doi: 10.1097/01.fpc.0000230414.74726.f6. Pharmacogenet Genomics. 2006. PMID: 17047486
Proteomic identification of aldo-keto reductase AKR1B10 induction after treatment of colorectal cancer cells with the proteasome inhibitor bortezomib.
Loeffler-Ragg J, Mueller D, Gamerith G, Auer T, Skvortsov S, Sarg B, Skvortsova I, Schmitz KJ, Martin HJ, Krugmann J, Alakus H, Maser E, Menzel J, Hilbe W, Lindner H, Schmid KW, Zwierzina H. Loeffler-Ragg J, et al. Among authors: alakus h. Mol Cancer Ther. 2009 Jul;8(7):1995-2006. doi: 10.1158/1535-7163.MCT-08-0987. Epub 2009 Jun 30. Mol Cancer Ther. 2009. PMID: 19567817
134 results